PTPRC and acute myeloid leukemia: However, in support of in vivo CDX disease profiling (Figure 5B), LAIR-1 engagement by NC525 did cause a reduction in AML cells (represented by human CD45+ cells) in the bones of CDX mice (Figure 6C, left).